US equities |
MU $909.29 ▲+3.62% TSLA $393.74 ▲+5.78% NVDA $215.99 ▲+2.39% SPCX $148.11 ▲+0.42% META $632.04 ▼-1.65% AAPL $342.86 ▼-1.40% SNDK $1,262.79 ▲+2.00% INTC $91.42 ▲+5.12%
FinancialContent

Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

6.410 -0.230 (-3.46%)
Delayed Quote Updated: 3:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
DTIL Stock Earnings: Precision BioSciences Misses EPS, Misses Revenue for Q4 2023 ↗
DTIL stock results show that Precision BioSciences missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Earnings Preview: Precision BioSciences ↗
 
Via Benzinga
News headline image
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy
From Precision BioSciences
Via Business Wire
News headline image
Earnings Scheduled For March 27, 2024 ↗
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
News headline image
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
SPX, Nasdaq Look To Continue Rally ↗
Fresh off a fourth-straight monthly win on Wall Street, stocks are on the rise as the week winds down. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news! 
Via InvestorPlace
News headline image
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
From Precision BioSciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants
From Precision BioSciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness
From Precision BioSciences
Via Business Wire
News headline image
Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Effect a Reverse Stock Split
From Precision BioSciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Multiple Sclerosis Focused TG Therapeutics Stock Trading Higher Today? ↗
TG Therapeutics Inc (NASDAQ: TGTX) reported preliminary BRIUMVI U.S.  
Via Benzinga
News headline image
Why Precision BioSciences Stock Is Up Today ↗
Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement wit 
Via Benzinga
News headline image
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
From Precision BioSciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences to Present at Hep-DART 2023
From Precision BioSciences, Inc.
Via Business Wire
News headline image
Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
From Precision BioSciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >